These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation. Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830 [TBL] [Abstract][Full Text] [Related]
4. Notch in the kidney: development and disease. Sirin Y; Susztak K J Pathol; 2012 Jan; 226(2):394-403. PubMed ID: 21952830 [TBL] [Abstract][Full Text] [Related]
6. Regulation of EMT by Notch signaling pathway in tumor progression. Li Y; Ma J; Qian X; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z Curr Cancer Drug Targets; 2013 Nov; 13(9):957-62. PubMed ID: 24168187 [TBL] [Abstract][Full Text] [Related]
7. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Edeling M; Ragi G; Huang S; Pavenstädt H; Susztak K Nat Rev Nephrol; 2016 Jul; 12(7):426-39. PubMed ID: 27140856 [TBL] [Abstract][Full Text] [Related]
8. Notch signaling: an emerging therapeutic target for cancer treatment. Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688 [TBL] [Abstract][Full Text] [Related]
9. The story of Notch and chronic kidney disease. Sharma S; Sirin Y; Susztak K Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):56-61. PubMed ID: 21088575 [TBL] [Abstract][Full Text] [Related]
10. Notch3 and kidney injury: never two without three. Sanchez-Niño MD; Ortiz A J Pathol; 2012 Nov; 228(3):266-73. PubMed ID: 22952000 [TBL] [Abstract][Full Text] [Related]
11. [Notch signaling pathway and new strategies in cancer treatment]. Santos L; León-Galván MF; Marino-Marmolejo EN Salud Publica Mex; 2006; 48(2):155-65. PubMed ID: 16619872 [TBL] [Abstract][Full Text] [Related]
12. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells. Schwarzer R; Dörken B; Jundt F Leukemia; 2012 Apr; 26(4):806-13. PubMed ID: 21946908 [TBL] [Abstract][Full Text] [Related]
13. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases. Kumar R; Juillerat-Jeanneret L; Golshayan D J Med Chem; 2016 Sep; 59(17):7719-37. PubMed ID: 27045975 [TBL] [Abstract][Full Text] [Related]
14. Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal Diseases. Juillerat-Jeanneret L; Flohr A; Schneider M; Walter I; Wyss JC; Kumar R; Golshayan D; Aebi JD J Med Chem; 2015 Oct; 58(20):8097-109. PubMed ID: 26421850 [TBL] [Abstract][Full Text] [Related]
15. Myofibroblastic transformation of rat hepatic stellate cells: the role of Notch signaling and epithelial-mesenchymal transition regulation. Zhang QD; Xu MY; Cai XB; Qu Y; Li ZH; Lu LG Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4130-8. PubMed ID: 26592839 [TBL] [Abstract][Full Text] [Related]
16. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice. Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Borghese L; Dolezalova D; Opitz T; Haupt S; Leinhaas A; Steinfarz B; Koch P; Edenhofer F; Hampl A; Brüstle O Stem Cells; 2010 May; 28(5):955-64. PubMed ID: 20235098 [TBL] [Abstract][Full Text] [Related]